LATEST NEWS
Scancell gets FDA approval to move into final-stage trial for new melanoma treatment
26 . 01 . 26
Scancell has received approval from the US Food and Drug Administration (FDA) to begin a large, late-stage clinical trial of its skin cancer treatment, iSCIB1+ Immunobody®.
The Phase 3 trial, which is planned to start this year, will test...
Read More